All insights
June 2026·Market Insights

The trough was 2023: what 1,544 deals say about where private multiples actually went.

Across our proprietary deal universe, median V/EBITDA fell from 11.9x in 2021 to 7.5x in 2023, then snapped back past 14x — without waiting for a rate cut. Sellers anchored to 2021 comps and buyers anchored to 2023 comps are both negotiating off the wrong year. Two charts.

Griffin Advisory Group

There is a version of the last five years that everyone in the middle market tells from memory: multiples were high in 2021, the rate cycle crushed them, and they have been climbing back ever since. The memory is roughly right and precisely wrong, and the difference matters at the closing table.

We hold a proprietary database of 1,544 M&A transactions captured and tagged in-house, spanning May 2020 to mid-2026. Of those, 349 disclose a usable EBITDA multiple. Cut to the median by deal year, the data does not show a gentle compression and a gentle recovery. It shows a clean trough — and a recovery that overshot.

What the years actually say

Median V/EBITDA ran 10.8x in 2020, 11.9x in 2021, 8.8x in 2022, and bottomed at 7.5x in 2023 — a 37% decline from the 2021 peak. Then it reversed hard: 14.6x in 2024, 12.7x in 2025, and 11.7x across a partial 2026. The recovery did not merely retrace the cycle. At its 2024 reading it cleared the pre-cycle 2020 and 2021 medians outright.

The honest caveat sits in the sample. Annual counts run from 31 to 104 disclosed multiples, and disclosure skews toward private-equity and public transactions. These are medians on thin, biased annual cuts, not a continuous index. Read the direction and the magnitude, not the second decimal. The direction is unambiguous: a sharp trough in 2023 and an overshoot on the way out.

Column chart of median V/EBITDA by year across the Griffin deal universe: 10.8x in 2020, 11.9x in 2021, 8.8x in 2022, 7.5x in 2023, 14.6x in 2024, 12.7x in 2025, 11.7x in partial 2026, with the 2023 trough highlighted.
Griffin deal universe, 349 disclosed EBITDA multiples. The 2023 trough is 37% below the 2021 peak; 2026 is a partial year.
The recovery did not wait for cuts

Lay the multiple series against the ten-year Treasury and the conventional story breaks. Through 2023, the textbook held: the ten-year climbed from under 1% to roughly 4%, and multiples compressed into their trough. But from 2024 onward, rates stayed elevated — and multiples re-rated anyway. Buyers did not wait for the cost of money to fall before paying up again.

That is the read-through worth carrying into a process. The 2024–25 re-rating was not a rates story; it was a growth-and-scarcity story. Buyers re-priced quality assets in a high-rate world, which is a different and more durable phenomenon than a liquidity-driven bubble. A seller who assumes the recovery is fragile because rates are still high is misreading why it happened.

Dual-line chart of median V/EBITDA against the annual-average ten-year Treasury yield, 2020 to 2025, showing the multiple trough aligning with the rate peak and the recovery occurring while rates stayed elevated.
Multiples are Griffin universe medians; ten-year yields are public annual averages, rounded. The recovery occurred without rate relief.
What to do with it

The practical instruction is narrow. A comp set drawn from 2021 overstates today; a comp set drawn from 2023 understates it. The operative range is the most recent full-year reading for the relevant sub-sector, adjusted for the disclosure bias in the sample. Anchoring a negotiation to either extreme of the cycle hands the counterparty an argument.